RETIVU

Serial Number 97724847
732

Registration Progress

Application Filed
Dec 20, 2022
Under Examination
Apr 30, 2024
Approved for Publication
Oct 31, 2023
Published for Opposition
Oct 31, 2023
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Apr 30, 2026 87 days

Trademark Image

RETIVU

Basic Information

Serial Number
97724847
Filing Date
December 20, 2022
Published for Opposition
October 31, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
732
Status Date
Oct 2, 2025
Application
Pending
Classes
005

Rights Holder

EyePoint Pharmaceuticals US, Inc.

03
Address
C400
480 Pleasant Street
Watertown, MA 02472

Ownership History

EyePoint Pharmaceuticals US, Inc.

Original Applicant
03
Watertown, MA

EyePoint Pharmaceuticals US, Inc.

Owner at Publication
03
Watertown, MA

Legal Representation

Attorney
Kimberly A Jarman

USPTO Deadlines

Next Deadline
87 days remaining
NOA E-Mailed - SOU Required
Due Date
April 30, 2026
Extension Available
Until October 30, 2026

Application History

28 events
Date Code Type Description Documents
Oct 2, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 2, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 2, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 2, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 27, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 27, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 26, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 26, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 2, 2024 RGIA O REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED Loading...
Dec 2, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Dec 2, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jun 13, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 10, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 10, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 10, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 30, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 20, 2024 CHPB I POST PUBLICATION AMENDMENT - ENTERED Loading...
Mar 18, 2024 APET A ASSIGNED TO PETITION STAFF Loading...
Mar 10, 2024 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Feb 14, 2024 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED Loading...
Nov 30, 2023 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Oct 31, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 31, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 11, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 22, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 21, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 17, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 23, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Injectable pharmaceutical preparations for use by ophthalmologists, or other medical professionals qualified to administer ocular injections, for the treatment of eye diseases and conditions, excluding the treatment of cancer

Classification

International Classes
005